Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
The Oncologist|November 22, 2017
Anti-Hu-Associated Autoimmune Limbic Encephalitis in a Patient with PD-1 Inhibitor-Responsive Myxoid ChondrosarcomaKyriakos P Papadopoulos, Rebecca S Romero, Gabriela Gonzalez, et al.Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|May 15, 2012
Homonymous hemimacular thinning: a unique presentation of optic tract injury in neuromyelitis opticaRebecca S Romero, Ismael Gutierrez, Eugene Wang, et al.Clinical Neurology and Neurosurgery|July 28, 2020
Creutzfeldt-Jakob Disease: In-hospital demographics report of national data in the United States from 2016 and review of a rapidly-progressive caseEithan Kotkowski, John H Cabot, John V Lacci, et al.Radiology|February 2, 2021
Disruption of the Atrophy-based Functional Network in Multiple Sclerosis Is Associated with Clinical Disability: Validation of a Meta-Analytic Model in Resting-State Functional MRIFlorence L Chiang, Max Feng, Rebecca S Romero, et al.Neurology and Therapy|June 16, 2025
Real-World Treatment Outcomes in Black, Hispanic, Asian, and White People with Multiple Sclerosis Treated with Fumarates in the USASophia Woodson, Edward J Gettings, Chu-Yueh Guo, et al.Neurology and Therapy|June 16, 2025
Comparative Effectiveness of Fumarates Versus Sphingosine-1-Phosphate Receptor Modulators in Black Patients with Multiple SclerosisSophia Woodson, Edward J Gettings, Chu-Yueh Guo, et al.Journal of Neuroimmunology|March 25, 2025
Satralizumab treatment in patients with AQP4-IgG-seropositive neuromyelitis optica spectrum disorder after rituximab treatment: A case seriesHesham Abboud, Brian Steingo, Diana Vargas, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 12, 2025
Satralizumab treatment in adults with aquaporin-4 immunoglobulin G-seropositive neuromyelitis optica spectrum disorder in clinical practiceHesham Abboud, Brian Steingo, Diana Vargas, et al.Pageof 1